Comerica Bank Invitae Corp Transaction History

Comerica Bank

  • $23.8 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$0.42 - $0.72 $479 - $822
-1,142 Reduced 18.1%
5,169 $3,000
Q3 2023

Nov 21, 2023
BUY
$0.6 - $1.53 $3,786 - $9,655
6,311 New
6,311 $3,000
Q1 2021

Apr 28, 2021
SELL
$33.06 - $56.93 $136,207 - $234,551
-4,120 Closed
0 $0
Q4 2020

Jan 28, 2021
BUY
$39.09 - $57.4 $161,050 - $236,488
4,120 New
4,120 $172,000

Others Institutions Holding NVTA

# of Institutions
38
Shares Held
2.12M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Comerica Bank Portfolio

Follow Comerica Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email